Selected research
Market Structure
Global Pharmaceutical Grade Vitamin B12 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmaceutical Grade Vitamin B12 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pharmaceutical Grade Vitamin B12 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Grade Vitamin B12 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Grade Vitamin B12 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmaceutical Grade Vitamin B12 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Grade Vitamin B12 include EUROAPI, Eisai Co., Ltd, HTBA, North China Pharmaceutical Company, Ningxia Kingvit Pharmaceutical, Cspc Holdings Company and Yufeng Industry Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pharmaceutical Grade Vitamin B12 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Grade Vitamin B12 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Grade Vitamin B12 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade Vitamin B12 market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmaceutical Grade Vitamin B12 Segment by Company
EUROAPI
Eisai Co., Ltd
HTBA
North China Pharmaceutical Company
Ningxia Kingvit Pharmaceutical
Cspc Holdings Company
Yufeng Industry Group
Pharmaceutical Grade Vitamin B12 Segment by Type
Adenosylcobalamin
Cyanocobalamin
Hydroxocobalamin
Methylcobalamin
Pharmaceutical Grade Vitamin B12 Segment by Application
Oral Formulation
Sprays
Injectable Formulation
Pharmaceutical Grade Vitamin B12 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Vitamin B12 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Vitamin B12 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Vitamin B12.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharmaceutical Grade Vitamin B12 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Grade Vitamin B12 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Grade Vitamin B12 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pharmaceutical Grade Vitamin B12 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Adenosylcobalamin
- Cyanocobalamin
- Hydroxocobalamin
- Methylcobalamin
Applications
- Oral Formulation
- Sprays
- Injectable Formulation
Companies covered
- EUROAPI
- Eisai Co., Ltd
- HTBA
- North China Pharmaceutical Company
- Ningxia Kingvit Pharmaceutical
- Cspc Holdings Company
- Yufeng Industry Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Grade Vitamin B12 Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Grade Vitamin B12 Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pharmaceutical Grade Vitamin B12 Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pharmaceutical Grade Vitamin B12 Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pharmaceutical Grade Vitamin B12 Market Dynamics
- 2.1 Pharmaceutical Grade Vitamin B12 Industry Trends
- 2.2 Pharmaceutical Grade Vitamin B12 Industry Drivers
- 2.3 Pharmaceutical Grade Vitamin B12 Industry Opportunities and Challenges
- 2.4 Pharmaceutical Grade Vitamin B12 Industry Restraints
3 Pharmaceutical Grade Vitamin B12 Market by Manufacturers
- 3.1 Global Pharmaceutical Grade Vitamin B12 Revenue by Manufacturers (2021-2026)
- 3.2 Global Pharmaceutical Grade Vitamin B12 Sales by Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Grade Vitamin B12 Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Grade Vitamin B12 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Grade Vitamin B12 Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pharmaceutical Grade Vitamin B12 Manufacturers, Product Type & Application
- 3.7 Global Pharmaceutical Grade Vitamin B12 Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharmaceutical Grade Vitamin B12 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharmaceutical Grade Vitamin B12 Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharmaceutical Grade Vitamin B12 Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Grade Vitamin B12 Market by Type
- 4.1 Pharmaceutical Grade Vitamin B12 Type Introduction
- 4.1.1 Adenosylcobalamin
- 4.1.2 Cyanocobalamin
- 4.1.3 Hydroxocobalamin
- 4.1.4 Methylcobalamin
- 4.2 Global Pharmaceutical Grade Vitamin B12 Sales by Type
- 4.2.1 Global Pharmaceutical Grade Vitamin B12 Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Grade Vitamin B12 Sales by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Grade Vitamin B12 Sales Market Share by Type (2021-2032)
- 4.3 Global Pharmaceutical Grade Vitamin B12 Revenue by Type
- 4.3.1 Global Pharmaceutical Grade Vitamin B12 Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pharmaceutical Grade Vitamin B12 Revenue by Type (2021-2032)
- 4.3.3 Global Pharmaceutical Grade Vitamin B12 Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Grade Vitamin B12 Market by Application
- 5.1 Pharmaceutical Grade Vitamin B12 Application Introduction
- 5.1.1 Oral Formulation
- 5.1.2 Sprays
- 5.1.3 Injectable Formulation
- 5.2 Global Pharmaceutical Grade Vitamin B12 Sales by Application
- 5.2.1 Global Pharmaceutical Grade Vitamin B12 Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Grade Vitamin B12 Sales by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Grade Vitamin B12 Sales Market Share by Application (2021-2032)
- 5.3 Global Pharmaceutical Grade Vitamin B12 Revenue by Application
- 5.3.1 Global Pharmaceutical Grade Vitamin B12 Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pharmaceutical Grade Vitamin B12 Revenue by Application (2021-2032)
- 5.3.3 Global Pharmaceutical Grade Vitamin B12 Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Grade Vitamin B12 Sales by Region
- 6.1 Global Pharmaceutical Grade Vitamin B12 Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Grade Vitamin B12 Sales by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Grade Vitamin B12 Sales by Region (2021-2026)
- 6.2.2 Global Pharmaceutical Grade Vitamin B12 Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Grade Vitamin B12 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharmaceutical Grade Vitamin B12 Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Grade Vitamin B12 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharmaceutical Grade Vitamin B12 Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharmaceutical Grade Vitamin B12 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharmaceutical Grade Vitamin B12 Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pharmaceutical Grade Vitamin B12 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pharmaceutical Grade Vitamin B12 Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pharmaceutical Grade Vitamin B12 Revenue by Region
- 7.1 Global Pharmaceutical Grade Vitamin B12 Revenue by Region
- 7.1.1 Global Pharmaceutical Grade Vitamin B12 Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pharmaceutical Grade Vitamin B12 Revenue by Region (2021-2026)
- 7.1.3 Global Pharmaceutical Grade Vitamin B12 Revenue by Region (2027-2032)
- 7.1.4 Global Pharmaceutical Grade Vitamin B12 Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pharmaceutical Grade Vitamin B12 Revenue (2021-2032)
- 7.2.2 North America Pharmaceutical Grade Vitamin B12 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pharmaceutical Grade Vitamin B12 Revenue (2021-2032)
- 7.3.2 Europe Pharmaceutical Grade Vitamin B12 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pharmaceutical Grade Vitamin B12 Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pharmaceutical Grade Vitamin B12 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pharmaceutical Grade Vitamin B12 Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pharmaceutical Grade Vitamin B12 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 EUROAPI
- 8.1.1 EUROAPI Company Information
- 8.1.2 EUROAPI Business Overview
- 8.1.3 EUROAPI Pharmaceutical Grade Vitamin B12 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 EUROAPI Pharmaceutical Grade Vitamin B12 Product Portfolio
- 8.1.5 EUROAPI Recent Developments
- 8.2 Eisai Co., Ltd
- 8.2.1 Eisai Co., Ltd Company Information
- 8.2.2 Eisai Co., Ltd Business Overview
- 8.2.3 Eisai Co., Ltd Pharmaceutical Grade Vitamin B12 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Eisai Co., Ltd Pharmaceutical Grade Vitamin B12 Product Portfolio
- 8.2.5 Eisai Co., Ltd Recent Developments
- 8.3 HTBA
- 8.3.1 HTBA Company Information
- 8.3.2 HTBA Business Overview
- 8.3.3 HTBA Pharmaceutical Grade Vitamin B12 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 HTBA Pharmaceutical Grade Vitamin B12 Product Portfolio
- 8.3.5 HTBA Recent Developments
- 8.4 North China Pharmaceutical Company
- 8.4.1 North China Pharmaceutical Company Company Information
- 8.4.2 North China Pharmaceutical Company Business Overview
- 8.4.3 North China Pharmaceutical Company Pharmaceutical Grade Vitamin B12 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 North China Pharmaceutical Company Pharmaceutical Grade Vitamin B12 Product Portfolio
- 8.4.5 North China Pharmaceutical Company Recent Developments
- 8.5 Ningxia Kingvit Pharmaceutical
- 8.5.1 Ningxia Kingvit Pharmaceutical Company Information
- 8.5.2 Ningxia Kingvit Pharmaceutical Business Overview
- 8.5.3 Ningxia Kingvit Pharmaceutical Pharmaceutical Grade Vitamin B12 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Ningxia Kingvit Pharmaceutical Pharmaceutical Grade Vitamin B12 Product Portfolio
- 8.5.5 Ningxia Kingvit Pharmaceutical Recent Developments
- 8.6 Cspc Holdings Company
- 8.6.1 Cspc Holdings Company Company Information
- 8.6.2 Cspc Holdings Company Business Overview
- 8.6.3 Cspc Holdings Company Pharmaceutical Grade Vitamin B12 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Cspc Holdings Company Pharmaceutical Grade Vitamin B12 Product Portfolio
- 8.6.5 Cspc Holdings Company Recent Developments
- 8.7 Yufeng Industry Group
- 8.7.1 Yufeng Industry Group Company Information
- 8.7.2 Yufeng Industry Group Business Overview
- 8.7.3 Yufeng Industry Group Pharmaceutical Grade Vitamin B12 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Yufeng Industry Group Pharmaceutical Grade Vitamin B12 Product Portfolio
- 8.7.5 Yufeng Industry Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pharmaceutical Grade Vitamin B12 Value Chain Analysis
- 9.1.1 Pharmaceutical Grade Vitamin B12 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pharmaceutical Grade Vitamin B12 Production Mode & Process
- 9.2 Pharmaceutical Grade Vitamin B12 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharmaceutical Grade Vitamin B12 Distributors
- 9.2.3 Pharmaceutical Grade Vitamin B12 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst